Adiponectin has been shown to have anti-diabetic, anti-atherosclerotic and anti-inflammatory effects, however, the level of adiponectin has been reported to be lower in obese individuals and in those with diabetes and vascular disease [39]. This evidence concerns the gene ADIPOQ and diabetes mellitus.